Cerebrospinal fluid excitatory amino acids and tau protein in children with acute lymphoblastic leukemia treated according to the BFM protocol

Acta Haematologica

Volumn 112, Issue 4, 2004, Pages 222-224

  Holownia, Adam ^a   Trofimiuk, Emil ^a   Krawczuk Rybak, Maryna ^a   Jakubow, Piotr ^a   Kaliszewski, Jacek ^a   Muszynska Roslan, Katarzyna ^a   Braszko, Jan J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ASPARTIC ACID; FOLINIC ACID; GLUTAMIC ACID; METHOTREXATE; TAU PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANALYSIS OF VARIANCE; ARTICLE; BEHAVIOR DISORDER; CANCER CHEMOTHERAPY; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEUKOENCEPHALOPATHY; LINEAR REGRESSION ANALYSIS; LUMBAR PUNCTURE; NEUROENDOCRINE DISEASE; NEUROTOXICITY; POLAND; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; ASPARTIC ACID; CHILD; DAUNORUBICIN; EXCITATORY AMINO ACIDS; GLUTAMIC ACID; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; PREDNISONE; TAU PROTEINS; VINCRISTINE;

EID: 9144235885     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081278     Document Type: Article

References (10)

1. Cortes J: Central nervous system involvement in adult acute lymphocytic leukemia. Hematol/Oncol Clin North Am 2001;15:145-162.
2. Choudhry VP, Krishnamurthy L, Rath GK, Arya LS, Pati H, Saraya AK: Efficacy of intrathecal methotrexate with and without cranial radiotherapy in preventing central nervous system relapses in acute lymphocytic leukemia. Indian Pediatr 1992;29:843-849.
3. Brain E, Alexandre J, Minozzi C, Misset JL: High-dose methotrexate and cerebral neurotoxicity. A propos of a case of arachnoiditis. Presse Méd 1997;26:265-268.
4. Shuper A, Stark B, Kornreich L, Cohen IJ, Avrahami G, Yaniv I: Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia. Isr Med Assoc J 2002;4:1050-1053.
5. Kim L, Glantz MJ: Neoplastic meningitis. Current Treatment Options in Oncology 2001;2:517-527.
6. Baumgartner WA, Redmond M, Brock M, Tseng E, Blue ME, Troncoso JC, Johnston MV: Pathophysiology of cerebral injury and future management. J Card Surg 1997;12(2suppl):300-310.
7. Korinthenberg R, Ullrich K, Ritter J, Stephani U: Electrolytes, amino acids and proteins in lumbar CSF during the treatment of acute leukemia in childhood. Acta Paediatr Scand 1990;79:335-342.
8. Meldrum BS: Glutamate as a neurotransmitter in the brain: Review of physiology and pathology. J Nutr 2000;130(4S suppl):1007S-1015S.
9. Higuchi M, Lee VM, Trojanowski JQ: Tau and axonopathy in neurodegenerative disorders. Neuromolec Med 2002;2:131-150.
10. Van Gool SW, Van Kerschaver E, Brock P, Pottel H, Hulstaert F, Vanmechelen E, Uyttebroeck A, Van De Voorde A, Vanderstichele H: Disease- and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignancies. Leukemia 2000;14:2076-2084.